drugset / Trial / NCT00333047

Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy

NCT00333047

Phase 2/3 Completed 24 enrolled Novartis
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Therapeutic interventions for patients with metastatic breast cancer are aimed at prolonging survival and improving the quality of life. The objective of this trial is to assess if an initial chemotherapy followed by an endocrine therapy leads to a longer disease-free interval as compared to chemotherapy alone.

Timeline

Start
2002-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified

Indications